Status:
COMPLETED
2 Year Follow up of COSGOD III
Lead Sponsor:
Medical University of Graz
Collaborating Sponsors:
Medical University Innsbruck
Medical University of Vienna
Conditions:
Neurodevelopmental Disability
Death
Eligibility:
All Genders
18-30 years
Brief Summary
The COSGOD III trial performed follow up until term age or discharge from the neonatal intensive care unit, whatever came first. The first neonate was randomised in September 2017 and the last in Octo...
Eligibility Criteria
Inclusion
- \> 50% 2 year neurodevelopmental outcome assessment at 2 years (18 to 30 months)
Exclusion
- \< 50% 2 year neurodevelopmental outcome assessment at 2 years (18 to 30 months)
Key Trial Info
Start Date :
January 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2024
Estimated Enrollment :
417 Patients enrolled
Trial Details
Trial ID
NCT06141733
Start Date
January 1 2024
End Date
December 31 2024
Last Update
March 13 2025
Active Locations (11)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of Graz
Graz, Austria
2
Medical University Innsbruck
Innsbruck, Austria
3
Medical University Vienna
Vienna, Austria
4
University of Alberta
Edmonton, Canada